• Lotte Steuten, Karin Lemmens, and Bert Vrijhoef.
• Care and Public Health Research Institute, Maastricht University, 6200 MD Maastricht, the Netherlands. l.steuten@zw.unimaas.nl
• Curr Opin Allergy Clin Immunol. 2007 Jun 1; 7 (3): 242-8.

Purpose Of ReviewTo provide a critical opinion on the extent to which asthma disease management programs currently improve the effectiveness and efficiency of care and directions for future policy and research.Recent FindingsThe methodological quality of health technology assessment of asthma disease management programs remains moderate. Asthma disease management programs are predominantly educational and organizational in nature and focus either on children or on adults. Paediatric disease management programs make more effort to outreach into patients' living environments and show higher participation rates than those targeting adults. Reductions in asthma-related hospitalization, emergency department, and unplanned clinic visits range from 0 to 85%, 87% and 71%, respectively. Aspects of self-management and organization of care improved after the implementation of disease management programs. Almost no impact on asthma symptoms, lung function or the use of long-term control medication was found.SummaryThere is accumulating 'circumstantial' evidence that disease management programs reduce resource utilization. The analytical rigor and uniformity of health technology assessment of asthma disease management programs has improved, but the generalizability of results remains uncertain. Practical, multicentre, clinical trials including broad representative study samples should be performed in different settings to increase methodological quality and substantiate current findings.

7 keywords...

hide…